United States
Germany
Japan
United Kingdom
China
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6F8 (formerly 6F8)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Products
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI7E7 (formerly 7E7)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4D10 (formerly 4D10)
| Applications | IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
热销推荐
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI7C9 (formerly 7C9)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAPK1 (tGFP-tagged) - Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI1D3 (formerly 1D3)
| Applications | IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,990.00
2周
CNY 3,990.00
2周
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
QC Levels
Pathways
- Acute myeloid leukemia (97)
- Adherens junction (97)
- Alzheimer's disease (97)
- Axon guidance (97)
- B cell receptor signaling pathway (97)
- Bladder cancer (97)
- Chemokine signaling pathway (97)
- Chronic myeloid leukemia (97)
- Colorectal cancer (97)
- Dorso-ventral axis formation (97)
- Endometrial cancer (97)
- ErbB signaling pathway (97)
- Fc epsilon RI signaling pathway (97)
- Fc gamma R-mediated phagocytosis (97)
- Focal adhesion (97)
- Gap junction (97)
- Glioma (97)
- GnRH signaling pathway (97)
- Insulin signaling pathway (97)
- Long-term depression (97)
- Long-term potentiation (97)
- MAPK signaling pathway (97)
- Melanogenesis (97)
- Melanoma (97)
- NOD-like receptor signaling pathway (97)
- Natural killer cell mediated cytotoxicity (97)
- Neurotrophin signaling pathway (97)
- Non-small cell lung cancer (97)
- Oocyte meiosis (97)
- Pancreatic cancer (97)
- Pathways in cancer (97)
- Prion diseases (97)
- Progesterone-mediated oocyte maturation (97)
- Prostate cancer (97)
- Regulation of actin cytoskeleton (97)
- Renal cell carcinoma (97)
- T cell receptor signaling pathway (97)
- TGF-beta signaling pathway (97)
- Thyroid cancer (97)
- Toll-like receptor signaling pathway (97)
- Type II diabetes mellitus (97)
- VEGF signaling pathway (97)
- Vascular smooth muscle contraction (97)
- mTOR signaling pathway (97)
